LXRX
LXRX
NASDAQ · Pharmaceuticals

Lexicon Pharmaceuticals Inc

$2.05
+0.02 (+0.74%)
As of Sep 20, 10:26 PM ET ·
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Buy 8 73%
Hold 3 27%
Sell 0 0%
Price Target
Analyst Price Target +776.6% upside
Low Target $15.16
Average Target $17.97
High Target $22.64
Current Price $2.05
Current
$2.05
Target
$17.97
$15.16 $17.97 avg $22.64
Scenario Analysis
Bear Case
$15.16
639.5%
Low target
Base Case
$17.97
+776.6%
Avg target
Bull Case
$22.64
+1,004.4%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$2.68
-23.5% from high
52-Week Low
$1.06
+93.4% from low
Target vs 52W High
$17.97
+570.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%